Bepotastine besilate nasal spray: Phase II started

Ista began a placebo-controlled, U.S. Phase II trial to evaluate twice-daily bepotastine besilate nasal spray for 2 weeks in about 600 patients with allergic rhinitis due to Mountain Cedar pollen. Ist...